Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShort-Term Debt repayments
Ratios

Abvc Biopharma (ABVC) Loans and Notes Receivables (2018 - 2020)

Historic Loans and Notes Receivables for Abvc Biopharma (ABVC) over the last 3 years, with Q4 2020 value amounting to $696255.0.

  • Abvc Biopharma's Loans and Notes Receivables rose 10865.82% to $696255.0 in Q4 2020 from the same period last year, while for Dec 2020 it was $696255.0, marking a year-over-year increase of 10865.82%. This contributed to the annual value of $696255.0 for FY2020, which is 10865.82% up from last year.
  • Latest data reveals that Abvc Biopharma reported Loans and Notes Receivables of $696255.0 as of Q4 2020, which was up 10865.82% from $632517.0 recorded in Q3 2020.
  • Abvc Biopharma's 5-year Loans and Notes Receivables high stood at $769421.0 for Q2 2020, and its period low was $40000.0 during Q3 2018.
  • For the 3-year period, Abvc Biopharma's Loans and Notes Receivables averaged around $313512.6, with its median value being $251707.0 (2019).
  • As far as peak fluctuations go, Abvc Biopharma's Loans and Notes Receivables skyrocketed by 70669.5% in 2019, and later surged by 9602.11% in 2020.
  • Over the past 3 years, Abvc Biopharma's Loans and Notes Receivables (Quarter) stood at $59477.0 in 2018, then skyrocketed by 461.03% to $333682.0 in 2019, then surged by 108.66% to $696255.0 in 2020.
  • Its Loans and Notes Receivables stands at $696255.0 for Q4 2020, versus $632517.0 for Q3 2020 and $769421.0 for Q2 2020.